Skip to main content
. 2010 Sep 5;59(12):1877–1884. doi: 10.1007/s00262-010-0914-1

Table 2.

852A dose administration

Patient Total doses received Max dose received Number of maximum doses received Dose reduction Treatment discontinued Reason
1 24 1.2 14 No No
2 12 1.2 5 Yes Yes Disease progression
3 9 1.2 3 No Yes Disease progression
4 6 1 2 No Yes Nausea/vomiting
5 1 0.6 1 No Yes EF-15%
6 10 1.2 4 No Yes Fatigue
7 5 1 1 No Yes Disease progression
8 24 1.2 18 No No
9 12 1.2 6 No Yes Disease progression
10 37 1.2 31 No During second course Anorexia, nausea/vomiting
11 24 1.2 2 Yes No
12 2 0.6 2 No Yes Non-ST elevated MI
13 14 1.2 8 No Yes Disease progression
14 0 DOD before first dose

DOD dead of disease